Rathe, Susan K.
Popescu, Flavia E.
Johnson, James E.
Watson, Adrienne L.
Marko, Tracy A.
Moriarity, Branden S.
Ohlfest, John R.
Largaespada, David A.
Article History
Received: 6 August 2018
Accepted: 19 November 2018
First Online: 23 January 2019
Competing Interests
: D.A.L. is the co-founder and co-owner of several biotechnology companies including NeoClone Biotechnologies, Inc., Discovery Genomics, Inc. (recently acquired by Immunsoft, Inc.), and B-MoGen Biotechnologies, Inc. He consults for Surrogen, Inc., and Genentech, Inc. is funding some of his research. B.S.M. is a co-founder and co-owner of B-MoGen Biotechnologies, Inc. A.L.W. is an employee and shareholder of Recombinetics Inc. The business of all these companies is unrelated to the contents of this manuscript. Other authors have no conflict of interest to disclose.